Results 21 to 30 of about 5,263 (229)

Amphetamine-Dextroamphetamine-Induced Cardiomyopathy, an Emerging Cause of Heart Failure in Young Patient Populations: A Case Study Involving the Study Drug

open access: yesCureus, 2023
Amphetamine-Dextroamphetamine-induced cardiomyopathy has become an emerging cause of heart failure in teenage and young adult populations. With its increasingly widespread use for the treatment of attention-deficit/hyperactivity disorder (ADHD) as well ...
Jennaire Lewars, Karen Wiarda
semanticscholar   +1 more source

Are Amphetamine/dextroamphetamine Doses Related to Prior History of Drug Abuse?

open access: yes, 2019
Class of 2019 Abstract and PosterSpecific Aims: The aim of this study was to see if there was a difference between the doses of amphetamine/dextroamphetamine being prescribed to patients that are using illicit substances.
Rahim, Hatef, Pourshams-Manzouri, Tania
core   +4 more sources

Eradication of Long-Term Vaginismus Type of Genito-Pelvic Pain/ Penetration Disorder by Treating with Dextroamphetamine Sulfate

open access: yesGynecology & Reproductive Health, 2023
There are many therapies for the vaginismus type of genito-pelvic pain/penetration disorder. However, as frequently found when there are multiple treatments for a given pathological disorder, not any of them are highly effective for this problem.
Jerome H. Check, D. Check
semanticscholar   +1 more source

The Therapeutic Potential of Amphetamine-like Psychostimulants

open access: yesLife, 2023
This review delves into the therapeutic applications of amphetamine-type stimulants such as lisdexamphetamine dimesylate, mixed amphetamine salts, 3,4-methylenedioxymethamphetamine (MDMA), dextroamphetamine, and phentermine.
Bruno Pires   +6 more
doaj   +1 more source

Population Pharmacokinetic-Pharmacodynamic Modeling of Variable Wear Times for a Dextroamphetamine Transdermal System

open access: yesCNS Spectrums, 2023
Introduction The Dextroamphetamine Transdermal System (d-ATS) was developed as an alternative to oral amphetamine (AMP) formulations for ADHD. In a pivotal study, d-ATS met primary and secondary efficacy endpoints for ADHD in children and adolescents ...
Mariacristina Castelli   +7 more
semanticscholar   +1 more source

Ginkgo biloba as an adjunct to methylphenidate in the treatment of attention deficit hyperactivity disorder in children: review of articles [PDF]

open access: yesReviews in Clinical Medicine, 2015
Attention-deficit/hyperactivity disorder is one of the most common psychiatric disorders in childhood. The medications which inhibit the reuptake of noradrenline and dopamine including psychostimulants such as methylphenidate and dextroamphetamine and ...
Paria Hebrani   +2 more
doaj   +3 more sources

Abuse of Pharmaceutical Drugs and Its Prevention

open access: yesFayixue Zazhi, 2021
Abuse of pharmaceutical drugs is a major public health and social problem worldwide. Mostly abused drugs mainly include opioids such as morphine, tramadol, methadone and fentanyl, sedative-hypnotics such as benzodiazepines and non-benzodiazepines, and ...
MENG Shi-qiu, SHI Jie
doaj   +1 more source

Dextroamphetamine Treatment for Children With Hypothalamic Obesity

open access: yesJournal of the Endocrine Society, 2021
Introduction: Hypothalamic obesity (HO) in children can be either genetic or acquired, as a result of a suprasellar tumor or its treatment. HO, resulting from hyperphagia and/or a decreased resting energy expenditure (REE), may have devastating ...
J. van Schaik   +13 more
semanticscholar   +1 more source

Stimulant Therapy of ADHD and Tourette Syndrome

open access: yesPediatric Neurology Briefs, 1997
The effects of methylphenidate (MPH) and dextroamphetamine (DEX) on tic severity in 20 boys with ADHD and comorbid Tourette syndrome were investigated in a 9-week, placebo-controlled, double-blind crossover study at the Child Psychiatry Branch, NIMH ...
J Gordon Millichap
doaj   +1 more source

Home - About - Disclaimer - Privacy